Left Behind™. Orsini Specialty Pharmacy holds accreditations with the Accreditation Commission for Health Care (ACHC), The Joint Commission, URAC and NABP. Orsini has earned URAC's Rare Disease Pharmacy Center of Excellence Designation and ACHC's...
agreement with Novelty Nobility, a biotech company specializing in the development of antibody-based therapeutics, for the joint research and development of a novel treatment for geographic atrophy (GA). Age-related macular degeneration (AMD), one...
18F or 68Ga for PET imaging, or with therapeutic isotopes such as 177Lu or 225Ac for radioligand therapy, all of which are joined together by a modifiable linker which can be used to modulate important pharmacokinetic characteristics. Radiohybrid...
cells and proteins behave in biological systems. Promega Instrumentation Portfolio: GloMax® Galaxy Bioluminescence Imager joins an existing portfolio of detection instruments developed by Promega. GloMax® microplate readers and luminometers are...
cancer patients. City of Hope researchers are evaluating whether this cannabinoid therapeutic candidate could address joint pain (arthralgia) that is often a side effect of aromatase inhibitors, a type of hormone therapy used to treat...
Brandon Capital Partners and US-based HealthCare Ventures, followed by a further financing led by OneVentures with UQ joining the most recent financing.
Sergio Santillana, MD, MSc, MBA, as Chief Medical Officer (CMO). "As our new chief medical officer, Dr. Sergio Santillana joins our leadership team at a pivotal time as we plan to submit our first IND this year and build new levels of momentum in...
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced its collaboration with Roche to integrate Lunit SCOPE PD-L1 22C3 TPS into Roche's navify® Digital Pathology platform. This marks...
include the Desktop Lid Holder, Sample Flask Holder, Sensor Height Adjustment Adapter, and Condenser with Flexible Joint. These additions offer improved ergonomics, secure handling, and more precise sensor placement, making autoclaving and other...
to market." Dr. Schneider brings almost two decades of experience as a bacterial geneticist and microbiome researcher. She joins Corundum Systems Biology from Takeda Ventures where she managed investment in novel therapeutic modality platforms,...
of prosetin in ALS participants. The inaugural ClAB Chair is Angela Genge, MD, FRCP(C), eMBA (McGill University), who is joined by members Jinsy Andrews, MD, MSc (Columbia University), Leonard van den Berg, MD, PhD (UMC Utrecht), and Merit...
deployed AI platform in pathology, delivering high-quality solutions that set new standards in healthcare.” Ann Costello Joins Ibex Board of Directors: Ibex welcomed Ann Costello to its Board of Directors in April. With a distinguished career in...
them to gain real-world acceptance of their brands and make a difference in patients' lives. “It was important for me to join an organization that had the building blocks to create Customer Engagement solutions that combine strategy, insights and...
with HERA since the 2022 mpox outbreak, initially through direct procurement agreements, followed by the signing of a joint procurement agreement which has enabled EU Member States and additional countries in the European Economic Area (EEA) as...
decades of experience in ophthalmic product development, FDA and EU submissions, approvals, and market commercialization. Joining Mitro is former Aerie executive Marvin Garrett as senior vice president of regulatory affairs and safety. Garrett has...
areas, reinforcing its commitment to the community and the pharmaceutical industry at large." Tidewater Clinical Research joins Eximia's growing national network of integrated sites, and their respective practice leaders who welcome the new team as...
and high-performance self-care products to promote a healthier lifestyle. Under this segment Innocan has established a Joint Venture by the name of BI Sky Global Ltd. For more information please visit, https://innocanpharma.com/
activity against the major classes of proteases that are responsible for the majority of cartilage catabolism in arthritic joints, while maintaining its broad-spectrum anti-protease activity against serine and threonine proteases. "Our...
the Collaborative Influenza Vaccine Innovation Centers (CIVICs). Tiba was also recently accepted into BLUE KNIGHT ™, a joint initiative between Johnson & Johnson Innovation – JLABS ('JLABS') and BARDA, with an aim to harness innovation to combat...
Leqembi in the Nordic region, pending European approval, and currently Eisai and BioArctic are preparing for a joint commercialization in the region. About lecanemab (generic name, brand name: Leqembi®): Lecanemab (Leqembi) is the result of a...
